Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.

Joseph DomachowskeShabir Ahmed MadhiEric A F SimõesVictoria AtanasovaFernando CabañasKenji FurunoMaria L Garcia-GarciaIneta GrantinaKim A NguyenDennis BrooksYue ChangAmanda LeachTherese TakasYuan YuanM Pamela GriffinVaishali S MankadTonya Villafananull null

Published in: The New England journal of medicine (2022)

Keyphrases

preterm infants
heart failure
respiratory syncytial virus
low birth weight
respiratory tract
atrial fibrillation